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response against JeV in Mice
Muhammad Awais1, Ke Wang1, Xianwu Lin1, Wenjie Qian1, Nan Zhang1, Chong Wang1, 
Kunlun Wang1, Ling Zhao1, Zhen F. Fu1,2 and Min Cui1*
1 State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, 
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Japanese encephalitis virus (JEV) is a highly fatal pathogen to human beings. Toll-like 
receptor 7 (TLR7) plays a role as the first host defense against most single-stranded 
RNA flaviviruses. This study aims to investigate the role of TLR7 in inducing adaptive 
immune response in mice against JEV. In vitro and in vivo studies were conducted to 
examine the expression of toll-like receptors (TLRs) in mice. After JEV infection, physical 
parameters of mice (survival rate and body weight) were evaluated, and organs or cells 
were collected for further analysis. The expression of TLR7 was increased significantly 
as compare to other TLR molecules post-JEV infection. The expression of CD80, 
CD86, and CD273 on bone marrow-derived dendritic cells was increased significantly 
in TLR7−/− mice. Furthermore, viral load was also increased significantly in TLR7−/− mice 
as compare to C57BL/6 mice. But there was no significant difference among survival 
rate and body weight in TLR7−/− mice as compare to C57BL/6. Interestingly, we also 
found that TLR8 was upregulated in TLR7−/− mice. The study concluded that TLR8 was 
upregulated in TLR7-deficient mice, and it might play a compensatory role in the immune 
response in TLR7−/− mice.
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inTrODUcTiOn
Japanese encephalitis virus (JEV), a single-stranded RNA (ssRNA) virus, belongs to the family 
Flaviviridae that causes approximately 50,000 cases of encephalitis each year in human (1). Although 
JEV is endemic in many parts of the world, its prevalence is high in under-developed countries of 
the Asian subcontinent (2). The transmission dynamics and pathogenesis of JEV have been widely 
studied (3, 4); however, the molecular mechanism involved in Japanese encephalitis (JE) still requires 
detailed investigation. JE is transmitted by infected mosquitoes and affects the central nervous sys-
tem, resulting in encephalitis, meningitis, and poliomyelitis-like acute flaccid paralysis (5). JEV first 
amplify in periphery of the host in macrophages and dendritic cells (DCs) and, then, get entry into 
the CNS via the blood–brain barrier (BBB) (5). Within the CNS, JEV causes infection and directly 
kills the neurons (6). Viral replication within astrocytes and microglia cells has also been reported, 
which produces pro-inflammatory cytokines that cause indirect neuronal death (7).
Japanese encephalitis virus-specific T cells and virus neutralizing IgG and IgM antibodies perform 
a vital part in clearing the virus from CNS and peripheral lymphoid tissues (8). Emerging evidence 
also indicates that innate immune responses also play a crucial part for initial control of JEV infec-
tion and may also contribute to the inflammatory process (9, 10). Following viral infection, neurons 
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and other CNS cells actively respond and produce type I inter-
feron (IFN). The infection of West Nile Virus, another member 
of Flaviviridae family, also triggers the production of type 1 IFN 
(11). The virus prediction is done through MDA5 and RIG-I by 
pathogen-associated molecular patterns, which function as host 
germ-line pattern recognition receptors (PRRs) (12). Ablation of 
these PRRs and their downstream signaling molecules (MAVS) 
or transcriptional activators interferon regulatory transcription 
factor (IRF-3 and IRF-7) results in greatly enhanced susceptibility 
to WNV infection (13). There is also accumulating evidence that 
the type 1 IFN pathway may be activated through the recognition 
of toll-like receptors (TLRs) (14, 15). RIG-I and MDA5 recognize 
RNA or ssRNA in the cytosol and subsequently transmit signals 
through the adaptor molecule MAVS. Surface bound or endoso-
mal TLRs recognize both ssRNA and dsRNA and signal through 
Myd88 and TRIF molecules (16, 17).
Neurotropic flaviviruses trigger innate immune responses 
in both a MyD88-dependent and MyD88-independent 
manner, suggesting the involvement of TLR signaling in 
flaviviral-mediated immune responses (18). A recent study of 
TLR-deficient mice indicated that TLR4 and TLR3 have dis-
tinct signaling functions after JEV infection. TLR3-deficient 
mice were highly susceptible to JE. TLR3−/− mice exhibited 
increased pro-inflammatory cytokines and increased BBB 
permeability. Significantly enhanced viral loads were also 
observed in TLR3-deficient mice. TLR4-deficient mice 
demonstrated enhanced resistance to JEV infection. TLR4 
deficiency induced potent type I IFN responses through 
enhanced stimulation of antiviral ISG genes by different 
activation of IRF-3 and NF-κB in DCs and macrophages (19). 
In contrast, no protective role of TLR4 has been reported in 
cases of WNV infection. TLRs interact with the viral replica-
tion products and transmit signals through a series of adaptor 
molecules, resulting in the production of pro-inflammatory 
cytokines (20). Both toll-like receptor 7 (TLR7) and TLR8 
recognize ssRNA, and the recognition may have species 
specificity. Murine TLR7 and human TLR8 recognize SS 
GU-rich RNA as a natural ligand (21). Stimulation of TLR7 
or TLR8 results in the subsequent activation of TRIF and 
MyD88-dependent signaling pathways that, in turn, induce 
the expression of pro-inflammatory cytokines, chemokine’s, 
and type 1 IFNs.
The role of TLRs in flaviviral infections remains elusive 
because of conflicting data. Previous studies have indicated 
that TLR7 recognizes WNV and is capable of mediating innate 
immune responses. However, an in vivo study reported that abla-
tion of TLR7 in encephalitis due to JEV did not have significant 
progression effect (19). Furthermore, there was no change in 
susceptibility to JEV infection in TLR7-deficient mice. In addi-
tion, a recent study conducted by Nazmi and co-workers reported 
increased survival in mice treated with a TLR7 agonist compared 
with wild-type mice due to the use of lethal dose of JEV (GP78 
strain, 3 × 105 pfu/mouse) through subcutaneous route to induce 
infection. The reasons for the discrepancy in these results are 
unclear. Therefore, we aimed to determine whether the TLR7 
signaling pathway modulates innate immune responses and viral 
pathogenesis following JEV infection in TLR7-deficient mice.
MaTerials anD MeThODs
Mice
TLR7−/− mice were provided as a courtesy by Dr. Ling Zhao, 
Huazhong Agricultural University. C57BL/6 mice were provided 
by Provincial Center for Disease prevention and control Hubei; 
Wuhan, China, and were transferred to the experimental station 
under the guidance of the general experimental animal transfer 
protocol. All mice were kept under specific-pathogen-free condi-
tions (SPF). Experiments were performed on 6- to 8-week-old 
animals. Mice were separately housed according to their age and 
sex and grouped for identification and experimentation under 
identical conditions.
Virus and cells
The P3 strain of JEV generated from a Beijing isolate was used 
for both in vitro and in vivo studies. Inoculum of 15 μl of 5 × 104 
PFU of JEV-P3 virus was intracerebrally injected into the brain 
of 1-day-old suckling mice for the purpose of propagation (22). 
The morbid mice were euthanized and the brains were dissected. 
The brain tissue was homogenized to make 10% suspension 
(weight/volume) in Dulbecco Modified Eagle Medium. Then the 
prepared homogenate was centrifuged to remove cellular debris. 
The supernatant was separated and stored at −80°C. The virus 
titration was done in baby hamster kidney fibroblast cell line 
following the previously prescribed protocol (22).
Bone Marrow Preparation
Mice were kept under SPF conditions in our own facility follow-
ing the instructions of laboratory protocols. All of the procedures 
were performed under a safety cabin. Femurs and tibiae of 
TLR7−/− and C57BL/6 mice were dissected, and the bones were 
kept free from muscle by rubbing with a tissue cleaner. For 
disinfection, the bones were placed in 70% ethanol up to 5 min 
and then washing was done with phosphate buffer saline (PBS). 
Disinfected bone ends were cut using autoclaved scissors, and the 
bone marrow was extracted into sterilized petri plates using PBS 
with the help of a syringe having a 0.45-mm diameter needle. The 
isolated material was pipetted to breakdown clumping and was 
then filtered into 50-ml tubes (Corning Centristar™) by a nylon 
cell separator with 0.40-µm pores (Falcon®, Corning, NY, USA). 
The filtrate was centrifuged at 12,000 rpm for 5 min. After one 
wash, the bone marrow cells were resuspended in RPMI 1640, 
USA culture media. Approximately 3.6 ×  106 leukocytes were 
obtained per femur or tibia after washing.
Bone Marrow cell culture with gM-csF
Introduction of GM-CSF into bone marrow-derived dendritic 
cells (bmDCs) was conducted as previously described (23, 24). 
Isolated bone marrow cells were plated in 12-well cell culture 
plates (LabServ®, Fisher Scientific, China) at a density of 2 × 106 
cells/ml in DC media [RPMI 1640 supplemented with 10% FBS 
(Gibco, Grand Island, NY, USA), 100 µg/ml streptomycin, 100 Ul/
ml penicillin, and 10 ng/ml of rmGM-CSF and IL-4]. The incuba-
tion of these plates was performed at 37°C along with 5% CO2 in 
the incubator. Every 2 days post-culture, half of the supernatant 
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media was exchanged with fresh DC culture media. On day 11, 
bmDCs were harvested for further processing.
JeV-P3 infection of bmDcs
The JEV-P3 virus stock was diluted and prepared prior to infect-
ing the bmDCs. The cells were infected with a prepared JEV-P3 
virus at 1 MOI. Plates of infected bmDCs were incubated at 37°C 
with 5% CO2. The samples for RNA extraction and flow cytometry 
were taken at 12, 24, 48, and 72 h post-infection. The supernatant 
was removed before sampling, and the cells were placed in Trizol® 
Reagent (Invitrogen™, New Zealand) prior to storage at −80°C 
until further use for RNA extraction.
JeV-P3 inoculums in Mice
Total 25 of 6- to 8-week-old TLR7−/− mice and 25 of C57BL/6 
mice were allocated separately for animal experimentation under 
SPF conditions following the standard protocol. Mice were 
intravenously inoculated with JEV-P3 except for the control mice 
(n = 5) if needed. The dose rate of JEV-P3 was 1 × 105 pfu/mouse, 
which was diluted with PBS at a pH of 7.4 and a final volume 
of 100 µl. The control animals were injected with the same dose 
of PBS by the same route. The animals were monitored at 2-day 
intervals for any clinical symptoms, mortality, and measurement 
of body weight. Data were recorded from the beginning until the 
end of the experiment. Some mice were sacrificed under sterile 
conditions on the day that they exhibited clinical symptoms, and 
tissue (brain and spleen) was collected from both TLR7−/− and 
C57BL/6 mice. The dissected samples were preserved at −80°C 
until for further molecular analysis.
Quantitative real-time Pcr to Detect Viral 
load and cytokine expression
The tissue culture samples for RNA extraction were retrieved 
from −80°C storage and thawed for further processing. The viral 
RNA was extracted according to the given protocol (25). The 
extracted RNA was introduced for reverse transcription using a 
ReverTra Ace-α kit (Toyobo, Japan) in accordance with manufac-
turer’s directions. Quantitative reverse-transcription polymerase 
chain reaction (qRT-PCR) was accomplished by SYBR Green 
Real-Time PCR Master Mix (Takara, Japan) in accordance with 
manufacturer’s directions. The mRNA expression levels were 
normalized relative to β-actin. Data were calculated as the fold 
difference in the treatment compared with the control groups. 
Viral cDNA was detected using the JEV C gene specific forward 
and reverse primers.
Flow cytometry
Cell arrangement and flow analysis were conducted as described 
earlier (26). Rat anti-mouse monoclonal antibodies (eBioscience) 
were used for incubation of cells; fluorescence in isothiocyanate 
(FITC)-conjugated CD3, FITC- or phycoerythrin (PE)-
conjugated CD4, antigen-presenting cell (APC)-conjugated CD8, 
FITC-conjugated CD11b, PE- or PE-Cy7-conjugated CD11c, 
FITC-conjugated CD19, APC-conjugated CD25, PE-Vio770-
conjugated CD45R, PE-conjugated CD80, APC-conjugated 
CD86, APC-conjugated CD185 (CXCR5), PE-conjugated 
CD278 (ICOS), Percp-Cy5.5-conjugated CD279 (PD-1), 
FITC-conjugated PDCA-1, and/or APC-conjugated Gr-1 for 
30  min at 4°C; after that it was washed using cold PBS before 
the flow analysis. Isotype-matched rat anti-mouse IgG antibod-
ies (eBioscience) served as a negative control. Stained cells were 
analyzed on a FACS Calibur (BD) flow cytometry machine, and 
further calculations were performed with Graph pad software.
immunohistochemistry
The brain samples were collected from TLR7-deficient mice and 
C57BL/6 mice at the day 5 after JEV infection to determine the 
expression of TLR8 by using the immunohistochemical staining. 
In immunofluorescence, sections were incubated with primary 
rabbit anti-TLR8 pAb (1:50; abcam, China), followed by incuba-
tion with secondary antibody anti-rabbit IgG conjugated with 
Alexa Fluor 546. The same sections were then incubated with 
DAPI for nuclear counterstaining. Sections were imaged by using 
a fluorescence microscope (Olympus). Each group consists of 
(N = 3) mouse. The results were analysis after three independent 
experiments. TLR8 expression was analyzed through 10 fields of 
view (Figure 4C). The data were obtained and processed using 
Adobe Photoshop CS5 software (Adobe Systems, Pasadena, 
CA, USA).
statistical analysis
Data was expressed as the means ± SEs (SEM). One-way analysis 
of variance subsequent to Tukey’s post hoc tests and two-tailed 
Student’s t-test was used to calculate the differences among dif-
ferent groups. Graphs were plotted and analyzed using GraphPad 
Prism, version 5.0 (GraphPad Software, La Jolla, CA, USA) (27).
resUlTs
JeV infection Triggers Tlr7 Upregulation
The JEV-P3 inoculated mice were monitored for the expression of 
two types of TLRs (TLR7 and TLR8) using qRT-PCR. Spleen cells 
from infected mice were used to check the expression of these 
TLRs. A threefold increase in TLR7 expression was observed, 
while TLR8 expression did not change significantly (Figure 1A). 
Based on these results, we selected TLR7 for further analysis. 
DCs represent the most important cell population in the initia-
tion immune responses and serve as a bridge between innate and 
adaptive immunity. Furthermore, intracellular TLRs (TLR7 and 
TLR8) play a major role in the immune response against viral 
ssRNA through DCs. To further confirm the increase in TLR7 
expression following JEV infection, bmDCs were introduced by 
JEV-P3 for infection on day 11 post-culture. TLR7 expression was 
determined by qRT-PCR at different time points (12, 24, 48, and 
72 h) following infection. There was a 1.5-fold increases in TLR7 
upregulation at 48 and 72 h. At 48 h post-infection, there was a 
significant rise in TLR7 expression (p < 0.001) (Figure 1B).
Tlr7 Deficiency Did not change 
survivorship and Body Weight
Because the TLR7−/− mouse strain was generated from the 
C57BL/6 strain, the latter were used as a control to compare 
JEV susceptibility. To determine the precise role of TLR7 in JEV 
FigUre 1 | expression of toll-like receptors after Japanese encephalitis virus (JeV) infection. (a) The expression of toll-like receptor 7 (TLR7), and TLR8 
on the spleen after JEV infection in C57BL/6 mice. (B) The expression analysis of TLR7 on bone marrow-derived dendritic cells. C57BL/6 mice were infected with 
JEV, and the TLR7 expression rate was determined by quantitative reverse-transcription polymerase chain reaction at different time intervals (12, 24, 48, and 72 h). 
The real-time PCR results were analyzed by the ΔΔCt method and expressed as 2−∆Ct. The results are from three independent experiments. The data are presented 
as the mean ± SEM (***p < 0.001).
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pathogenesis, TLR7-deficient mice were inoculated with JEV 
(105  pfu) intravenously. The infected mice were monitored at 
2-day intervals for clinical symptoms, survivorship, and body 
weight. Less than a 10% increase in mortality was observed in 
TLR7-deficient mice compared with controls, which was not 
significant (Figure 2A). Similarly, the difference in body weight 
among TLR7-deficient and control mice groups was non-
significant (Figure 2B). The above results indicate that genetic 
differences have no impact on the progression of neuroinflam-
mation in JEV infection.
increased Viral load in the Brain of Tlr7-
Deficient Mice
To compare the viral load between C57BL/6 and TLR7−/− mice, 
brain samples were assessed with qRT-PCR amplification of 
the viral C-gene. After inoculation of virus, some animal show 
clinical symptom from fourth or fifth days and some does not 
show clinical symptom in whole experimental process in both 
TLR7−/− and C57BL/6 groups. Based on the clinical symptoms, 
mice were further sub-divided into two groups, asymptomatic 
(WO) and symptomatic group (W) for the C57BL/6 mice and 
TLR7−/− mice. It consists of n ≥ 5 mice for each group. Viral load 
was significantly increasing in symptomatic TLR7−/− mice com-
pared with C57BL/6 mice (p < 0.0001), the difference between 
asymptomatic TLR7−/− and C57BL/6 mice was non-significant 
(Figure 3). Therefore, the JEV burden was greater in the brain 
tissue of TLR7−/− mice than C57BL/6 mice in the symptomatic 
group, indicating that TLR7 plays a role in JEV infection.
response of Tlr8 in Tlr7-Deficient Mice 
Post-JeV infection
Previous results showed that TLR7 may have an antiviral function 
in JEV infection. However, there were no significant differences 
in the survival rate. The innate immune system is highly sophis-
ticated, and its pathways engage in considerable crosstalk. The 
question arose whether other TLRs played compensatory roles in 
the immune response to JEV in TLR7-deficient mice. To answer 
this question, we analyzed the expression of other TLRs (TLR3 
and TLR8) in TLR7-deficient mice. Interestingly, increased 
expression of TLR8 was observed in both the spleen and brain 
of JEV-infected TLR7-deficient mice (p <  0.0001). More than 
a 10-fold increase in TLR8 was observed in brain tissue, while 
approximately a 2-fold increase was observed in the spleen of 
TLR7−/− mice compared with C57BL/6 mice (Figures  4A,B). 
Based on previous results, the expression of TLR8 in brain was 
further determined through immunohistochemical staining. 
The increased expression of TLR8 was also observed in TLR7-
deficient mice as compare to C57BL/6 mice following JEV infec-
tion; while the expression of TLR8 was not significantly increase 
in uninfected TLR7-deficient mice as compare to C57BL/6 mice 
group (Figure 4C).
response of surface stimulatory and 
inhibitory Molecules in Tlr7-Deficient 
Mice
The surface cell stimulator ligands CD80 and CD86 are key 
factors in the initiation and maintenance of immune responses. 
In TLR7−/− and C57BL/6 mice, the expression of some surface 
cell stimulators, such as CD80 and CD86, and inhibitors, such 
as CD274 and CD273, in JEV-infected bmDCs was subsequently 
confirmed through flow cytometry. The results revealed that the 
expression of the surface stimulators CD80 and CD86 increased 
at 48 and 72  h after JEV infection in TLR7−/− mice compared 
with the control group (p < 0.0102; p < 0.0083). There were no 
significant differences in JEV-infected C57BL/6 mice compared 
with control mice (Figures 5A,B). The expression of CD273 (cell 
surface inhibitor) was also significantly increased at 48 and 72 h 
(p < 0.0041). More than a 10% increase was observed in the JEV-
infected group compared with the control group in TLR7−/− mice 
at each time point (Figure  5C). Compared with control mice, 
bmDCs from TLR7−/− mice showed a dramatical increase on both 
CD86 and CD273 (Figure 5D).
FigUre 3 | Toll-like receptor 7 (Tlr7) knock-out resulted in increased 
viral load in the brain following Japanese encephalitis virus (JeV)-
infection. TLR7−/− mice were inoculated with JEV (105 pfu), and the brain 
was collected after symptoms developed. Mice were divided to two groups 
according to the clinical signs. Once the clinical sign appeared, mouse has 
been sacrificed and samples have been collected as symptomatic groups (W) 
until 11 days of infection; and the left mice which did not show disease sign 
have been sacrificed at day 11 after infection and samples have been 
collected as asymptomatic (WO). The copy number of JEV-C genes in the 
brain was monitored with quantitative reverse-transcription polymerase chain 
reaction (qRT-PCR). The viral load was determined by qRT-PCR in the brain 
in the asymptomatic (WO) and symptomatic groups (W) of C57BL/6 and 
TLR7−/− mice following JEV infection. The real-time PCR results were 
analyzed by the ΔΔCt method and expressed as 2−∆Ct. The results are from 
three independent experiments. The data are presented as the mean ± SEM 
(***p < 0.001).
FigUre 2 | survivorship and body weight in toll-like receptor 7 (Tlr7)-deficient mice post-Japanese encephalitis virus (JeV) infection. Survival and 
body weight analysis in JEV-p3 infection, (a) 8-week-old age-matched C57BL/6 mice and TLR7−/− mice were intravenously injected with 105pfu of JEV-P3. 
Kalpan–Meier curves represent the survival distribution for mice over a period of 15 days, following challenge with n = 25 in each group. (B) The average of body 
weight change was monitored. Body weight was calculated every other day, beginning on day 0 until day 15. C57BL/6 infected group, n = 25; TLR7−/− infected 
group n = 25. The x axis represents the time after infection (days), while the y axis represents the percent survival (%) and body weight. Each group consisted of 
n = 25 animals. The data are taken from duplicate sets of experiments.
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responses of T subsets, Dc, and pDc in 
Tlr7-Deficient Mice
Dendritic cells are the most powerful APC. To make the transi-
tion from natural immunity to adaptive immunity, the changes in 
the T subsets, DC, and pDC in JEV infection, were investigated. 
The animals were divided into three groups, mock, asymptomatic 
(WO), and symptomatic (W), for both TLR7−/− and C57BL/6 
mice. T cell subsets, such as CD3+CD4+ and CD3+CD8+, were 
increased in the asymptomatic (WO) compared with the mock 
group. In TLR7−/− mice, the cell number of the CD4+ T subset 
was increased in the asymptomatic group (WO) compared with 
the mock and symptomatic groups (W) (Figure 6A). The ratio 
of CD11c+CD80+ was increased significantly in the symptomatic 
group (W) compared with the mock and asymptomatic groups 
(WO) in TLR7−/− mice. The ratio of CD11c+CD86+ was increased 
significantly in the asymptomatic group (WO) compared with 
the symptomatic (W) and mock groups in TLR7−/− mice. In 
C57BL/6 mice, the ratio of CD11c+CD80+ and CD11c+ CD86+ 
were altered in the asymptomatic (WO) and symptomatic groups 
compared with the mock group. The number of CD11c+CD80+ 
and CD11c+CD86+ showed no significant increase in TLR7−/− 
mice. In C57Bl/6 mice, the number of CD11c+CD80+ was not 
significantly increased, while the number of CD11c+CD86+ 
was significantly increased in the asymptomatic group (WO) 
compared with symptomatic (W) and mock groups (Figure 6B). 
The ratio of CD11c+PDCA+B220+ was increased in the asymp-
tomatic group (WO) compared with the mock and symptomatic 
groups (WO) in both TLR7−/− and C57BL/6 mice. The number of 
CD11c+PDCA+B220+ was significantly increased in the asymp-
tomatic group (WO) compared with the symptomatic (W) and 
mock groups only in C57BL/6 mice (Figure  6C). The ratio of 
the Treg subset of cells, such as CD4+CD25+ FOXP3+, changed 
in both the symptomatic (W) and asymptomatic groups (WO) 
compared with the mock group in C57BL/6 mice and TLR7−/− 
mice (Figure 6D). The number of CD4+CD25+FOXP3+ was sig-
nificantly increased in the asymptomatic group (WO) compared 
with the symptomatic (W) and mock groups in C57BL/6 mice, 
while the number of CD4+CD25+ FOXP3+ was not significantly 
increased in TLR7−/− mice.
DiscUssiOn
Toll-like receptors have been broadly accepted as the first line of 
defense in the host defense mechanism and serve to stimulate 
the innate immune response and trigger the initiation of the 
adaptive immune response (28). Although the RIG-1and MDA5 
in flaviviruses also initiate the type 1 IFN innate response in 
innate immunity (21, 29), the competency of TLRs as front line 
FigUre 4 | Toll-like receptor 8 (Tlr8) is upregulated in toll-like receptor 7 (Tlr7)-deficient mice following Japanese encephalitis virus (JeV) 
infection. (a) TLR8 expression in the asymptomatic (WO) and symptomatic groups (W) of brain samples was determined by quantitative reverse-transcription 
polymerase chain reaction (qRT-PCR) in TLR7−/− mice and C57BL/6 mice after JEV infection. (B) The expression of TLR8 in spleen samples was determined in the 
asymptomatic (WO) and symptomatic groups (W) by qRT-PCR after JEV infection. (c) TLR8 expression was determined on brain by immunofluorescence staining in 
TLR7-deficient mice and C57BL/6 mice after JEV infection (red dot for TLR8). DAPI stains for nuclei (blue). The real-time PCR results were analyzed by the ΔΔCt 
method and expressed as 2−∆Ct . The results are taken from three independent experiments. The data are presented as the mean ± SEM (*p < 0.05).
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FigUre 5 | stimulatory and inhibitory surface molecule response on bone marrow-derived dendritic cell (bmDc) in toll-like receptor 7 (Tlr7)-
deficient mice. (a,B) Co-stimulatory surface molecules of CD80 and CD86 were determined on bmDC in TLR7−/− and C57BL/6 mice at 48 and 72 h after 
Japanese encephalitis virus (JEV) infection. (c) The inhibitory molecule of CD273 was determine on bmDC in TLR7−/− and C57BL/6 mice at 48 and 72 h after JEV 
infection. (D) Co-stimulatory surface molecule and inhibitory molecules were determine on bmDC in TLR7−/− and C57BL/6 mice at 48 h after JEV infection (black 
line: control, blue line: JEV). The flow cytometry data were analyzed with GraphPad software. The results were expressed after three independent experiments. The 
data are presented as the mean ± SEM (*p < 0.05; **p < 0.01).
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activators of innate immunity has not been investigated in the 
inter- and intracellular space. To our knowledge, the role of TLRs 
in the defensive mechanism against the progression of JE disease 
has not been studied. We observed that TLR7 was upregulated in 
spleen samples in C57BL/6 mice compared to other TLRs. The 
expression level of TLR8 was also significantly increased in the 
spleen and brain tissue of TLR7-deficient mice compared with 
C57BL/6 mice post-JEV infection. The viral load was significantly 
increased in the brain tissue of TLR7-deficient mice compared 
with C57BL/6 mice post-JEV infection. JEV infection activated 
cells involved in innate immunity, such as DC and pDC, as well 
as cells that participate in adaptive immunity, such as CD4+ and 
CD8+ T cells, in TLR7-deficient mice.
A mouse model of WNV infection was used to study the 
role of TLR7 in triggering immunity (30). Previously, TLR7 was 
considered to be an immediate and principal defense element 
against ssRNA viral infection prior to viral replication in the host 
after entry (21). In a previous study, TLR7 was a highly efficient 
component of the JEV defense system, identifying viral ssRNA 
just after entry and before viral replication (31). In current study, 
we determined the expression levels of TLR7 and TLR8 signaling 
pathways on the spleen in C57BL/6 mice. We found that only the 
TLR7 signaling pathway was upregulated following intravenous 
JEV infection in C57BL/6 mice.
In a previous study, there was no difference in the survival rate 
between TLR7-deficient mice and wild-type controls after WNV 
infection (32). Moreover, compared to JEV-infected wild-type 
mice, the viral load was also significantly increased, and non-
significant difference was perceived in survivorship and body 
weight in TLR7-deficient mice (31). In the current investigation, 
we found an increased viral load in the brain of TLR7−/− mice, 
although there was non-significant difference in survivorship and 
body weight after JEV infection between TLR7-deficient mice and 
C57BL/6 mice. The inconsistency of survivorship with previous 
report may be because of different viral strains, infection doses, 
and routes. In the previous study, the authors used lethal dose of 
JEV (GP78 strain, 3 × 105 pfu/mouse) through subcutaneous route 
to induce infection (31). In another study the authors also used 
FigUre 6 | response of T subsets, dendritic cell (Dc), and pDc in toll-like receptor 7 (Tlr7)-deficient mice. (a) The expression of T subset 
CD3+CD4+CD8+ was determined in different groups, such as the asymptomatic (WO), mock, and symptomatic groups (W) in TLR7−/− mice and C57BL/6 mice. 
(B) Expression of the DC subset CD80+ CD11c+CD86+ was determined in the asymptomatic (WO), mock, and symptomatic groups (W) in TLR7 −/− mice and 
C57BL/6 mice after JEV infection. (c) The plasmacytoid DCs subset CD11c+mPDCA-1+CD45r/b220 was determine in the asymptomatic (WO), mock, and 
symptomatic groups (W) in TLR7−/− mice and C57BL/6 mice post-JEV infection. (D) The ratio of the Treg subset CD4+CD25+Foxp3+ was determined in the 
asymptomatic (WO), mock, and symptomatic groups in TLR7−/− mice and C57BL/6 mice post-JEV infection. Flow cytometry data were analyzed with GraphPad 
software. The results were expressed after three independent experiments. The data are presented as the mean ± SEM (*p < 0.05; **p < 0.01;***p < 0.001).
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lethal dose of JEV (Beijing-1 strain, 1.4 × 107 and 2.8 × 107 pfu/
mouse) through intraperitoneally route to induce infection (19). 
But in the present study, we used sub-lethal dose of JEV (P3 strain, 
1 × 105 pfu/mouse) by intravenous route to induce infection in 
mice. Different viral strains have different virulence. Moreover, 
we used the mice with same genetic background in which 
individual’s immunological differences may also exist, which 
provoked us to divide the mice into different groups according to 
their symptoms. Furthermore, there was less than a 10% increase 
in susceptibility to JEV infection in TLR7−/− mice, suggesting 
that the TLR7 response is not a main contributor to immunity 
following JEV infection. Surprisingly, we found that TLR8 was 
upregulated in TLR7-deficient mice compare with C57BL/6 
mice post-JEV infection. This finding implies that the similarity 
in the survival rate and body weight between TLR7−/− mice and 
C57BL/6 mice might due to the upregulation of TLR8. TLR8 may 
have a compensatory function in regulating the immune response 
to JEV infection in TLR7-deficient mice. TLR7 and TLR8 are 
phylogenetically very similar. Even the species-specific recogni-
tion has been reported that both human TLR8 and murine TLR7 
use single-stranded RNA as natural ligand (21). However, human 
TLR7 and TLR8 can activate independently the recognition of 
the same antiviral compound imidazoquinoline R-848 (33). There 
is possibility that the intermediates of viral replication stimulate 
TLR8 in TLR7-deficient mice. Based on the former studies, the 
current investigation helps to better understand the TLR7/8 func-
tion in mice. TLR7 expression varies depending on the cell type 
and may be compensatory to TLR8 expression, which is important 
for myeloid cells regulation. TLR8 may exert a regulatory influ-
ence on the immune response by controlling TLR7 expression. In 
the absence of TLR8, the expression of TLR7 was upregulated in 
DCs and highly responded to TLR7 ligands along with stronger 
NF-κB activation (34). The surface cell stimulator ligands CD80 
and CD86 play a vital part in the maintenance and initiation of the 
immune response against viral infections (35). In a previous study, 
we observed that stimulatory surface molecules were upregulated 
and pro-inflammatory cytokines were induced in C57BL/6 mice 
after infection (36). In this study, we also found that the expression 
of the surface stimulators CD80 and CD86 increased at 48 and 
72 h after JEV infection in TLR7−/− mice compared with control 
mice. Furthermore, the expression of CD273 (surface inhibitor 
cell) also significantly increased at 48 and 72 h in TLR7-deficient 
mice compared with control mice after JEV infection.
Type 1 IFN acts as bridge between innate and adaptive 
immunity (37, 38) by enhancing antigen-specific CD8+T cells 
(39) and CD4+T cells (40) and activating NK cells (41). In the 
previous study, T subsets were altered (19). We also investigated 
the change in the T subsets, DC response, and pDC response in 
JEV infection. We found an increase in the T subsets CD3+ CD4+ 
and CD3+ CD8+ in the JEV-infected group compared with the 
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mock group in TLR7-deficient mice. While in C57BL/6 mice, the 
ratio of T subsets were not significantly increased in JEV infected 
group as compare to mock group. Thus, TLR7 molecules act as 
central mediators among adaptive and innate immunity in JEV 
infection. In TLR7−/− mice, JEV infection induced higher levels of 
pDC and improved the responses of JEV-specific CD4+ and CD8+ 
T cells involved in viral clearance during the early and late phases 
of infection, respectively.
The DC subset and pDC subset of cells performs a key part in 
viral clearance following JEV infection (19). The pDC plays an 
important role in providing type 1 IFN in response to ssRNA virus 
infection (42). In the previous study, the ratio of the DC and pDCs 
subsets was increased in TLR4−/− JEV-infected mice compared 
with wild-type mice (43). In our study, the expression of pDCs 
was also increased in TLR7-deficient mice in the JEV-infected 
group compared with the mock group, which highlighted that 
TLR7 is important for the regulation of the pDC function in JEV 
infection. The ratio of the DC subset of cells, CD11c+ CD80+ and 
CD11c+ CD86+, was also significantly increased in TLR7−/− mice 
post-JEV infection compared with control mice. These results sug-
gest that TLR7 plays a more important role in the regulation of DC 
subsets of cells in JEV infection. The role of CD4+CD25+Foxp3+ 
in acute viral disease is still controversial (44, 45). Moreover, 
CD4+CD25+Foxp3+Treg cells contribute to the adaptive and 
innate immune responses during acute viral infection (43). In a 
previous study, the number and frequency of CD4+CD25+Foxp3+ 
were enhanced in TLR3−/− mice post-JEV infection (19). In the 
present study, TLR7 deficiency led to an increase in the ratio of 
the Treg subset of cells, CD4+CD25+Foxp3+, response in the JEV 
infected group compared with the control group.
Our in vitro and in vivo results suggest that TLR7 is compara-
tively superior to the other TLRs especially TLR8 and plays a very 
important role in the regulation of myeloid cells and the immune 
response against JEV infection. In TLR7-deficient mice, TLR8 
was upregulated and may also regulate the immune response and 
increase the survival rate following JEV infection. Future studies 
should investigate whether TLR8 is interlinked with TLR7 in the 
regulation of the immune response against JEV infection.
cOnclUsiOn
TLR8 is upregulated in TLR7−/− mice. Moreover, there is no 
significant difference in survival between TLR7-deficient and 
C57BL/6 mice. This may be because, in TLR7−/− mice, the TLR8 
signaling pathway is involved in the induction of immunity. An 
increased viral load in the brain was also observed in TLR7-
deficient mice. However, future research is needed to explore the 
underlying mechanism. It appears that the depletion of one TLR 
may be compensated for by another TLR.
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